These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19715753)

  • 21. Alterations of mitochondrial function in sepsis and critical illness.
    Harrois A; Huet O; Duranteau J
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):143-9. PubMed ID: 19390243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis.
    David S; Park JK; Meurs Mv; Zijlstra JG; Koenecke C; Schrimpf C; Shushakova N; Gueler F; Haller H; Kümpers P
    Cytokine; 2011 Aug; 55(2):251-9. PubMed ID: 21531574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.
    Zheng G; Lyu J; Huang J; Xiang D; Xie M; Zeng Q
    J Res Med Sci; 2015 Feb; 20(2):185-95. PubMed ID: 25983774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Neutrophil Gelatinase-Associated Lipocalin is Associated with Mortality and Multiple Organ Dysfunction Syndrome in Severe Sepsis and Septic Shock.
    Wang B; Chen G; Zhang J; Xue J; Cao Y; Wu Y
    Shock; 2015 Sep; 44(3):234-8. PubMed ID: 26009825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired regulation of cardiac function in sepsis, SIRS, and MODS.
    Werdan K; Schmidt H; Ebelt H; Zorn-Pauly K; Koidl B; Hoke RS; Heinroth K; Müller-Werdan U
    Can J Physiol Pharmacol; 2009 Apr; 87(4):266-74. PubMed ID: 19370080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and mitochondrial dysfunction in sepsis.
    Galley HF
    Br J Anaesth; 2011 Jul; 107(1):57-64. PubMed ID: 21596843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scavenging Circulating Mitochondrial DNA as a Potential Therapeutic Option for Multiple Organ Dysfunction in Trauma Hemorrhage.
    Aswani A; Manson J; Itagaki K; Chiazza F; Collino M; Wupeng WL; Chan TK; Wong WSF; Hauser CJ; Thiemermann C; Brohi K
    Front Immunol; 2018; 9():891. PubMed ID: 29867926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets.
    Ayala A; Perl M; Venet F; Lomas-Neira J; Swan R; Chung CS
    Curr Pharm Des; 2008; 14(19):1853-9. PubMed ID: 18691096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional cofactor treatment in mitochondrial disorders.
    Marriage B; Clandinin MT; Glerum DM
    J Am Diet Assoc; 2003 Aug; 103(8):1029-38. PubMed ID: 12891154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns.
    Huang YS; Yang ZC; Liu XS; Chen FM; He BB; Li A; Crowther RS
    Burns; 1998 Dec; 24(8):706-16. PubMed ID: 9915670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction.
    Crimi E; Sica V; Slutsky AS; Zhang H; Williams-Ignarro S; Ignarro LJ; Napoli C
    Free Radic Res; 2006 Jul; 40(7):665-72. PubMed ID: 16983993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polydatin: a new therapeutic agent against multiorgan dysfunction.
    Zeng Z; Chen Z; Li T; Zhang J; Gao Y; Xu S; Cai S; Zhao KS
    J Surg Res; 2015 Sep; 198(1):192-9. PubMed ID: 26095424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
    Wu JY; Tsou MY; Chen TH; Chen SJ; Tsao CM; Wu CC
    J Pineal Res; 2008 Aug; 45(1):106-16. PubMed ID: 18298464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Better therapy for combat injury.
    Yao YM; Zhang H
    Mil Med Res; 2019 Jul; 6(1):23. PubMed ID: 31340864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy.
    Prauchner CA
    Burns; 2017 May; 43(3):471-485. PubMed ID: 28034666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of Multiple Organ Failure in Sepsis.
    Rossaint J; Zarbock A
    Crit Rev Immunol; 2015; 35(4):277-91. PubMed ID: 26757392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? a review and a theoretical framework.
    Papathanassoglou ED; Moynihan JA; Ackerman MH
    Crit Care Med; 2000 Feb; 28(2):537-49. PubMed ID: 10708197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of sepsis on mitochondria.
    Garrabou G; Morén C; López S; Tobías E; Cardellach F; Miró O; Casademont J
    J Infect Dis; 2012 Feb; 205(3):392-400. PubMed ID: 22180620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of oxidative stress and mitochondrial respiratory chain dysfunction in an in vitro model of sepsis-induced kidney injury.
    Quoilin C; Mouithys-Mickalad A; Lécart S; Fontaine-Aupart MP; Hoebeke M
    Biochim Biophys Acta; 2014 Oct; 1837(10):1790-800. PubMed ID: 25019585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.